Validation of Software for Assessment of Atrial Fibrillation From Data Acquired by a Wearable Smartwatch

Completed

Conditions studied: Atrial Fibrillation

In brief

The goal of this study is to validate the Fitbit ECG software algorithm's ability to detect atrial fibrillation using data derived from a Fitbit wrist-worn consumer device that features a single lead ECG. The performance of the software application will be measured against centralized Core Lab physician-adjudicated 12-lead ECG tracings from FDA cleared ECG monitors as reference standards. The Fitbit software is intended as a pre-screening technology. It should identify candidates who may benefit from further evaluation. The software is not intended to be a diagnostic system.

Key facts

Study ID
NCT04176926
Run by
Fitbit LLC
People needed
472
Starts
2019-10-29
Expected to finish
2020-03-02
Last updated by the study team
2020-04-09

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.